• Publications
  • Influence
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.
BACKGROUND The CLASSIC trial was done to compare adjuvant capecitabine plus oxaliplatin versus observation after D2 gastrectomy for patients with stage II or III gastric cancer. The planned interimExpand
  • 466
  • 19
Recurrence following curative resection for gastric carcinoma
The diagnosis and treatment of recurrent gastric cancer remains difficult. The aim of this study was to determine the risk factors for recurrence of gastric cancer and the prognosis for theseExpand
  • 619
  • 17
Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.
BACKGROUND & AIMS Gastric cancer (GC) is a heterogeneous disease comprising multiple subtypes that have distinct biological properties and effects in patients. We sought to identify new, intrinsicExpand
  • 251
  • 10
  • PDF
Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer
Purpose: Despite continual efforts to develop a prognostic model of gastric cancer by using clinical and pathologic parameters, a clinical test that can discriminate patients with good outcomes fromExpand
  • 230
  • 10
  • PDF
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography
Positron emission tomography (PET) with 18‐ fluorodeoxyglucose (FDG) has been used to both detect and stage a variety of malignancies. The current study examined the value of PET for preoperativeExpand
  • 191
  • 9
  • PDF
Robotic spleen-preserving total gastrectomy for gastric cancer: comparison with conventional laparoscopic procedure
BackgroundRobotic systems recently have been introduced to overcome technical limitations of conventional laparoscopic surgery, especially for complex procedures. Laparoscopic spleen-preserving totalExpand
  • 96
  • 9
Robot-Assisted Gastrectomy With Lymph Node Dissection for Gastric Cancer: Lessons Learned From an Initial 100 Consecutive Procedures
Objective:To evaluate the technical feasibility, effectiveness, and safety of robot-assisted gastrectomy (RAG) with lymphadenectomy, using the da Vinci system through analyses of our initial seriesExpand
  • 229
  • 7
Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors
Activating mutations of KIT and platelet-derived growth factor receptor α (PDGFRA) are known to be alternative and mutually exclusive genetic events in the development of gastrointestinal stromalExpand
  • 88
  • 7
  • PDF
Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: A 15‐year experience at a single institute
The aim of this study was to investigate whether microscopic positive margins are detrimental to the outcome of gastric cancer patients treated with extended (D2/3) gastrectomy.
  • 67
  • 7
Putative chromosomal deletions on 9p, 9q and 22q occur preferentially in malignant gastrointestinal stromal tumors
  • N. Kim, J. Kim, +5 authors H. Kim
  • Biology, Medicine
  • International journal of cancer
  • 1 March 2000
To characterize the type of genetic alterations in gastrointestinal stromal tumors (GISTs), we performed a comprehensive allelotype study of 14 GISTs (2 benign, 7 borderline and 5 malignant) byExpand
  • 101
  • 7